NEOPLASMA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2024-02-29 Xi177 来自浙江省

偏重的研究方向：肺癌;肿瘤
经验分享：审稿4个月了还没有消息，有没有遇到这么久的……

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2018-05-24 ldtys

审稿速度:2.0 | 投稿命中率:75.0
经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式

252 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2023-04-11 ms5000002035322087 来自重庆

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：血液疾病
经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！

33 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2023-07-25 可乐雪碧来自上海

偏重的研究方向：肿瘤学;肿瘤;预后
经验分享：我有endnote格式，可以找我要

29 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2012-12-06 老虎uro

审稿速度:3.0
经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？

205 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2017-05-16 1dec4bd8m07(暂无匿称)

一月份投稿到现在还在一审中，快四个月了。这速度也是够了。

251 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2022-07-19 ms6000001632244600

为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2021-03-10 ms7000000220050012

求该杂志的endnote格式！

103 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2023-07-25 可乐雪碧来自上海

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。

40 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190099, encodeId=49a32190099eb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿4个月了还没有消息，有没有遇到这么久的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34d55316607, createdName=Xi177, createdTime=Thu Feb 29 14:50:31 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556394, encodeId=2ade556394fa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：二月份接收后再没有后续消息，系统登不上去，发邮件没有回复，向大神们求助这个杂志的联系方式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ce2075567, createdName=ldtys, createdTime=Thu May 24 12:06:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125077, encodeId=7c4d21250e765, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：血液疾病 经验分享：提醒每一个想投稿的人，慎重！！！！他那个投稿系统是自己的，和其他投稿系统都不一样，一旦你投了，是没办法撤稿的，没有撤稿的按钮，给编辑发消息撤稿也没用，我发了有三四封邮件，就没一封回复过，只有等，等很久，等送审意见回来了，你才能撤稿，真的很离谱，这个杂志也真的很慢。真的很无语，很后悔！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Tue Apr 11 13:18:42 CST 2023, time=2023-04-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2149852, encodeId=29ae214985241, content=偏重的研究方向：肿瘤学;肿瘤;预后 经验分享：我有endnote格式，可以找我要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 22:49:23 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=492771, encodeId=0ada492e7155, content=审稿速度:3.0 经验分享：已经三个多月了，催了两次还是在审稿，以前听说这个杂志挺快的，怎么现在这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老虎uro, createdTime=Thu Dec 06 09:14:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536764, encodeId=96e6536e64f7, content=一月份投稿到现在还在一审中，快四个月了。这速度也是够了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=155f1720421, createdName=1dec4bd8m07(暂无匿称), createdTime=Tue May 16 11:59:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233373, encodeId=5cd912333e393, content=为什么我投稿快5个月了，仍然还是processing，催了编辑4次，一次都没回，有没有大神求救一下，我该怎么办！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=403c6489877, createdName=ms6000001632244600, createdTime=Tue Jul 19 11:42:03 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947271, encodeId=60fe94e271fc, content=求该杂志的endnote格式！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05205466067, createdName=ms7000000220050012, createdTime=Wed Mar 10 22:52:22 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149717, encodeId=3a6c2149e171d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：3月5日投稿，期间审稿人给了14个问题，很详细回答，小修给了修改格式，6月25日，接受，前半年900欧元，后半年1800欧元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cf5464123, createdName=可乐雪碧, createdTime=Tue Jul 25 10:41:14 CST 2023, time=2023-07-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=510964, encodeId=bb5951096470, content=谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了 We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again. The following decision has now been reached: Minor revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51fe1616150, createdName=springroll2000, createdTime=Sat Apr 04 07:26:00 CST 2015, time=2015-04-04, status=1, ipAttribution=)]

2015-04-04 springroll2000

谢谢175.10.39.241，昨晚他们来邮件说小修，太激动了
We would like to inform you that your manuscript could be published in NEOPLASMA, however only in the case minor revision of the manuscript will be performed. Below are the reviewer′s remarks. Would you be so kind and prepare the revised version of the manuscript and we will submit it to the reviewers again.
The following decision has now been reached: Minor revision

124 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务